-

Eurofins Scientific SE: Purchases of Own Shares from March 31st to April 4th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins Scientific SE (Paris:ERF):

Name of the Issuer

Identity code of the Issuer

Day of the transaction

Identity code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC Code)

EUROFINS

529900JEHFM47DYY3S57

31/03/2025

FR0014000MR3

102,000

49.2861

XPAR

EUROFINS

529900JEHFM47DYY3S57

31/03/2025

FR0014000MR3

40,000

49.3084

CEUX

EUROFINS

529900JEHFM47DYY3S57

31/03/2025

FR0014000MR3

4,000

49.3217

TQEX

EUROFINS

529900JEHFM47DYY3S57

31/03/2025

FR0014000MR3

4,000

49.3194

AQEU

EUROFINS

529900JEHFM47DYY3S57

01/04/2025

FR0014000MR3

102,000

48.9818

XPAR

EUROFINS

529900JEHFM47DYY3S57

01/04/2025

FR0014000MR3

40,000

48.9497

CEUX

EUROFINS

529900JEHFM47DYY3S57

01/04/2025

FR0014000MR3

4,000

48.9907

TQEX

EUROFINS

529900JEHFM47DYY3S57

01/04/2025

FR0014000MR3

4,000

48.9940

AQEU

EUROFINS

529900JEHFM47DYY3S57

02/04/2025

FR0014000MR3

102,000

48.3167

XPAR

EUROFINS

529900JEHFM47DYY3S57

02/04/2025

FR0014000MR3

40,000

48.3426

CEUX

EUROFINS

529900JEHFM47DYY3S57

02/04/2025

FR0014000MR3

4,000

48.3532

TQEX

EUROFINS

529900JEHFM47DYY3S57

02/04/2025

FR0014000MR3

4,000

48.3471

AQEU

EUROFINS

529900JEHFM47DYY3S57

03/04/2025

FR0014000MR3

102,000

50.0030

XPAR

EUROFINS

529900JEHFM47DYY3S57

03/04/2025

FR0014000MR3

40,000

49.8861

CEUX

EUROFINS

529900JEHFM47DYY3S57

03/04/2025

FR0014000MR3

4,000

49.9008

TQEX

EUROFINS

529900JEHFM47DYY3S57

03/04/2025

FR0014000MR3

4,000

49.9076

AQEU

EUROFINS

529900JEHFM47DYY3S57

04/04/2025

FR0014000MR3

102,000

48.4888

XPAR

EUROFINS

529900JEHFM47DYY3S57

04/04/2025

FR0014000MR3

40,000

48.3324

CEUX

EUROFINS

529900JEHFM47DYY3S57

04/04/2025

FR0014000MR3

4,000

48.3328

TQEX

EUROFINS

529900JEHFM47DYY3S57

04/04/2025

FR0014000MR3

4,000

48.3391

AQEU

 

 

 

TOTAL

750,000

48.9997

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins Scientific SE

Eurofins Scientific SE

BOURSE:ERF
Release Versions
English

Contacts

Eurofins Scientific SE

More News From Eurofins Scientific SE

Eurofins Delivers FY 2025 Objectives with a 24% EPS Growth, Accelerating Organic Revenue Growth, Margin Expansion, and Higher Free Cash Flow and Confirms Its 2027 Objectives

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review section of this press release. Financial highlights in FY 2025 Basic EPS8 grew 24% to €2.31 in 2025 vs €1.87 in 2024, driven by a strong operating performance and starting to reap the benefits from Eurofins five-year investment programme in its hub and spok...

Eurofins: Weekly Report on Share Repurchases From 19th January to 23rd January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/01/2026 FR0014000MR3 5 000 71.7101 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/01/2026 FR0014000MR3 5 000 70.5398 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 14/01/...

Eurofins CDMO Alphora Announces Development & Implementation of AI-Powered Salt and Co-Crystal Screening Software

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the development and launch of a new AI-powered software for high throughput salt and co-crystal screening – now a core component of all solid-state screening programs. Developed by Eurofins CDMO Alphora, in collaboration with a local university, this cutting-edge machine learning platform provides highly accurate predictions of salt and co-crystal formation for APIs and intermediates. This breakthrough technolog...
Back to Newsroom